News
06-30-2013, 10:30 AM
A biomarker reflecting expression levels of two genes in tumor tissue may be able to predict which women treated for estrogen-receptor (ER)-positive breast cancer should receive a second estrogen-blocking medication after completing tamoxifen treatment.
More... (http://www.news-medical.net/news/20130630/Biomarker-indicates-which-women-are-at-risk-for-breast-cancer-recurrence-after-tamoxifen.aspx)
More... (http://www.news-medical.net/news/20130630/Biomarker-indicates-which-women-are-at-risk-for-breast-cancer-recurrence-after-tamoxifen.aspx)